Bayer Hopeful Of Sweet Success With KaNDy Buy

Gets Hold Of Late-Stage Non-Hormonal Menopause Drug

 
• By Kevin Grogan
  
KaNDy_Therapeutics
In demand: CEO Mary Kerr (c) and colleagues • Source: KaNDy Therapeutics
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business